Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

InterMune and Array BioPharma collaborate on hepatitis drug discovery

Oct. 2, 2002

Clinical efficacy and safety of ACH-126443 in HBV demonstrated in phase I/II clinical trial

Oct. 2, 2002

Efficacy of IS-741 on spontaneous colitis in transgenic rat model

Oct. 2, 2002

PARP inhibitor GPI-6150 effective in rat model of colitis

Oct. 2, 2002

Tanabe AAI signs development and licensing agreements for first three compounds

Sep. 30, 2002

Patient enrollment completed in phase IIb renzapride trial in IBS

Sep. 26, 2002

Functional fatty acid compound tested in patients with NASH in U.S. trial

Sep. 26, 2002

First nucleotide analogue for HBV approved by FDA

Sep. 25, 2002

New anti-H. pylori agents identified by American researchers

Sep. 25, 2002

Deligoparin does not meet endpoints of pivotal study in ulcerative colitis

Sep. 20, 2002

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...